載入...
ALK and ROS1 as a joint target for the treatment of lung cancer: a review
Rearrangements of the anaplastic lymphoma kinase (ALK) have been described in multiple malignancies, including non-small cell lung cancer (NSCLC). ALK fusions have gain of function properties while activating mutations in wild-type ALK can also occur within the tyrosine kinase domain. ALK rearrangem...
Na minha lista:
發表在: | Transl Lung Cancer Res |
---|---|
Main Authors: | , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Pioneer Bioscience Publishing Company
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4369855/ https://ncbi.nlm.nih.gov/pubmed/25806218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.03.1 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|